Defective regulation of the ryanodine receptor induces hypertrophy in cardiomyocytes |
| |
Authors: | Tomoyo Hamada Adel Mandl Noriaki Ikemoto |
| |
Affiliation: | a Boston Biomedical Research Institute, Cardiovascular Program, 64 Grove St., Watertown, MA 02472, USA b Department of Neurology, Harvard Medical School, Boston, MA 02115, USA |
| |
Abstract: | Recent studies on cardiac hypertrophy animal model suggest that inter-domain interactions within the ryanodine receptor (RyR2) become defective concomitant with the development of hypertrophy (e.g. de-stabilization of the interaction between N-terminal and central domains of RyR2; T. Oda, M. Yano, T. Yamamoto, T. Tokuhisa, S. Okuda, M. Doi, T. Ohkusa, Y. Ikeda, S. Kobayashi, N. Ikemoto, M. Matsuzaki, Defective regulation of inter-domain interactions within the ryanodine receptor plays a key role in the pathogenesis of heart failure, Circulation 111 (2005) 3400-3410). To determine if de-stabilization of the inter-domain interaction in fact causes hypertrophy, we introduced DPc10 (a peptide corresponding to the G2460-P2495 region of RyR2, which is known to de-stabilize the N-terminal/central domain interaction) into rat neonatal cardiomyocytes by mediation of peptide carrier BioPORTER. After incubation for 24 h the peptide induced hypertrophy, as evidenced by significant increase in cell size and [3H]leucine uptake. K201 or dantrolene, the reagents known to correct the de-stabilized inter-domain interaction to a normal mode, prevented the DPc10-induced hypertrophy. These results suggest that disruption of the normal N-terminal/central inter-domain interaction within the RyR2 is a causative mechanism of cardiomyocyte hypertrophy. |
| |
Keywords: | Ryanodine receptor Cardiomyocyte Hypertrophy Domain peptide Dantrolene Endothelin |
本文献已被 ScienceDirect 等数据库收录! |
|